AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug it acquired in its ...

The company's immunology portfolio, led by Skyrizi and Rinvoq, continues to thrive despite Humira's patent expiration, ...

Deal to create new multichannel video distributor also settles litigation. Nvidia gets another accolade. Citi gets defensive.